Evidence map›Paper›PMID 35456893›Full record

ArticleInternational journal of molecular sciences2022

Resveratrol Prevents Cytoarchitectural and Interneuronal Alterations in the Valproic Acid Rat Model of Autism.

Júlio Santos-Terra, Iohanna Deckmann, Giovanna Carello-Collar, Gustavo Della-Flora Nunes, Guilherme Bauer-Negrini, Gustavo Brum Schwingel, Mellanie Fontes-Dutra, Rudimar Riesgo, Carmem Gottfried

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Júlio Santos-TerraTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.ORCID 0000-0002-8079-452X
Iohanna DeckmannTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.ORCID 0000-0002-6423-1938
Giovanna Carello-CollarTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.
Gustavo Della-Flora NunesTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.ORCID 0000-0001-9323-3556
Guilherme Bauer-NegriniTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.ORCID 0000-0003-0956-557X
Gustavo Brum SchwingelTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.
Mellanie Fontes-DutraTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.
Rudimar RiesgoTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.
Carmem GottfriedTranslational Research Group in Autism Spectrum Disorder-GETTEA, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.ORCID 0000-0001-8838-1300
Universidade Federal do Rio Grande do Sul · BR

Funding

Institutos Nacionais de Ciência e Tecnologia 465489/2014-1
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder characterized by several alterations, including disorganized brain cytoarchitecture and excitatory/inhibitory (E/I) imbalance. We aimed to analyze aspects associated with the inhibitory components in ASD, using bioinformatics to develop notions about embryonic life and tissue analysis for postnatal life. We analyzed microarray and RNAseq datasets of embryos from different ASD models, demonstrating that regions involved in neuronal development are affected. We evaluated the effect of prenatal treatment with resveratrol (RSV) on the neuronal organization and quantity of parvalbumin-positive (PV+), somatostatin-positive (SOM+), and calbindin-positive (CB+) GABAergic interneurons, besides the levels of synaptic proteins and GABA receptors in the medial prefrontal cortex (mPFC) and hippocampus (HC) of the ASD model induced by valproic acid (VPA). VPA increased the total number of neurons in the mPFC, while it reduced the number of SOM+ neurons, as well as the proportion of SOM+, PV+, and CB+ neurons (subregion-specific manner), with preventive effects of RSV. In summary, metabolic alterations or gene expression impairments could be induced by VPA, leading to extensive damage in the late developmental stages. By contrast, due to its antioxidant, neuroprotective, and opposite action on histone properties, RSV may avoid damages induced by VPA.

Indexed as

Autism Spectrum DisorderAutistic DisorderPrenatal Exposure Delayed EffectsResveratrolValproic AcidAnimalsDisease Models, AnimalFemaleInterneuronsPregnancyRatsResveratrolValproic Acidautism spectrum disorderGABA receptorinterneuronresveratrolsynapsevalproic acid

Identifiers

PMID35456893
PMCPMC9027778
OpenAlexW4224228319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.